Novavax filed for authorization with Health Canada today for its protein-based COVID-19 vaccine. Stanley Erck, President & CEO, Novavax tells BNN Bloomberg that its vaccine can be mixed & matched with others and that it's scaling production globally.
Saturday, January 22, 2022
Novavax files for COVID-19 vaccine authorization with Health Canada
Novavax files for COVID-19 vaccine authorization with Health Canada:
Thursday, January 20, 2022
Thursday, January 13, 2022
Friday, January 7, 2022
Sunday, January 2, 2022
Subscribe to:
Posts (Atom)